Tumor Escape and Progression under Immune Pressure

• Tumor Escape and Progression under Immune Pressure, Masoud H. Manjili, Nejat Egilmez, Keith L. Knutson, Senthamil R. Selvan, and Julie R. Ostberg
  Volume 2012 (2012), Article ID 641079, 2 pages
• Role of Immune Escape Mechanisms in Hodgkin's Lymphoma Development and Progression: A Whole New World with Therapeutic Implications, Luis de la Cruz-Merino, Marylène Lejeune, Esteban Nogales Fernández, Fernando Henao Carrasco, Ana Grueso López, Ana Illescas Vacas, Mariano Provencio Pulla, Cristina Callau, and Tomás Álvaro
  Volume 2012 (2012), Article ID 756353, 24 pages
• Lessons from Cancer Immunoediting in Cutaneous Melanoma, Mariana Aris, María Marcela Barrio, and José Mordoh
  Volume 2012 (2012), Article ID 192719, 14 pages
• Hematological Malignancies Escape from NK Cell Innate Immune Surveillance: Mechanisms and Therapeutic Implications, Laure Farnault, Carole Sanchez, Céline Baier, Thérèse Le Treut, and Régis T. Costello
  Volume 2012 (2012), Article ID 421702, 8 pages
• Lung Cancer: A Classic Example of Tumor Escape and Progression While Providing Opportunities for Immunological Intervention, Martin R. Jadus, Josephine Natividad, Anthony Mai, Yi Ouyang, Nils Lambrecht, Sandor Szabo, Lisheng Ge, Neil Hoa, and Maria G. Dacosta-Iyer
  Volume 2012 (2012), Article ID 160724, 21 pages
• New Roads Open Up for Implementing Immunotherapy in Mesothelioma, R. Cornelissen, M. E. Heuvers, A. P. Maat, R. W. Hendriks, H. C. Hoogsteden, J. G. J. V. Aerts, and J. P. J. J. Hegmans
  Volume 2012 (2012), Article ID 927240, 13 pages
• Macrophages in Tumor Microenvironments and the Progression of Tumors, Ning-Bo Hao, Mu-Han Lü, Ya-Han Fan, Ya-Ling Cao, Zhi-Ren Zhang, and Shi-Ming Yang
  Volume 2012 (2012), Article ID 948098, 11 pages
• Novel Anti-Melanoma Immunotherapies: Disarming Tumor Escape Mechanisms, Sivan Sapoznik, Ohad Hammer, Rona Ortenberg, Michal J. Besser, Tehila Ben-Moshe, Jacob Schachter, and Gal Markel
  Volume 2012 (2012), Article ID 818214, 9 pages
• Immune Responses to RHAMM in Patients with Acute Myeloid Leukemia after Chemotherapy and Allogeneic Stem Cell Transplantation, R. Casalegno-Garduño, C. Meier, A. Schmitt, A. Spitschak, I. Hilgendorf, S. Rohde, C. Hirt, M. Freund, B. M. Pützer, and M. Schmitt
  Volume 2012 (2012), Article ID 146463, 9 pages
• Towards Curative Cancer Immunotherapy: Overcoming Posttherapy Tumor Escape, Gang Zhou and Hyam Levitsky
  Volume 2012 (2012), Article ID 124187, 12 pages
• T Cells in Gastric Cancer: Friends or Foes, Amedeo Amedei, Chiara Della Bella, Elena Silvestri, Domenico Prisco, and Mario M. D'Elios
  Volume 2012 (2012), Article ID 690571, 10 pages
• Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma, Hidenari Nagai, Takanori Mukozu, Daigo Matsui, Takenori Kanekawa, Masahiro Kanayama, Noritaka Wakui, Kouichi Momiyama, Mie Shinohara, Kazunari Iida, Koji Ishii, Yoshinori Igarashi, and Yasukiyo Sumino
  Volume 2012 (2012), Article ID 607851, 8 pages
• Immunological and Nonimmunological Effects of Indoleamine 2,3-Dioxygenase on Breast Tumor Growth and Spontaneous Metastasis Formation, Vera Levina, Yunyun Su, and Elieser Gorelik
  Volume 2012 (2012), Article ID 173029, 12 pages
• Programmed Death Ligand 2 in Cancer-Induced Immune Suppression, Esdy N. Rozali, Stanleyson V. Hato, Bruce W. Robinson, Richard A. Lake, and W. Joost Lesterhuis
  Volume 2012 (2012), Article ID 656340, 8 pages
• Releasing the Brake: Targeting Cbl-b to Enhance Lymphocyte Effector Functions, Stephanie Wallner, Thomas Gruber, Gottfried Baier, and Dominik Wolf
  Volume 2012 (2012), Article ID 692639, 5 pages